DNA-based mAbs (UPenn/Inovio/MedImmune)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDNA-based mAbs (UPenn/Inovio/MedImmune)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins modulators
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, HumanCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncMedimmune LlcUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsInfluenza, HumanCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A